Characteristics of individuals eligible for the clinic:
The Hereditary Gynaecologic Surveillance Clinic’s services are focused on offering long-term medical and emotional support to women who have a genetic mutation that is linked to a higher risk for developing gynaecological cancers. To be enrolled in this clinic, you must first be evaluated by the Jewish General Hospital’s Department of Medical Genetics or at the Genetics department of an alternate institution. If you were tested at an alternate institution, you must present a copy of your test results to the Clinical Care Coordinator (see below). For information regarding our Department of Medical
Genetics, please see Cancer Genetic Services.
BRCA1 and BRCA2 genes are the most important genes linked with the increased tendency to develop ovarian cancer. A family can have an increased tendency to develop breast and ovarian cancer if it has a mutation or an alteration in either of these genes. As well, the clinic also helps those women that have an increased tendency to develop colon cancer because this is linked with a higher risk of developing endometrial ovarian cancers.
The steps to take:
As mentioned above, to be part of this clinic, you must have been seen first by the Jewish General Hospital’s Department of Medical Genetics or present a letter to this clinic’s Clinical Care Coordinator showing that you were seen at another genetic institution. This is the first step.
For information regarding our Department of Medical Genetics, please click here. If you were seen at another institution’s genetic clinic, please direct the letter to the contact information for prospective patients provided at the bottom of this page.
If you were seen by our Department of Medical Genetics, if you wish, after you receive your test results your name will be given to the Clinical Care Coordinator. You will be given the choice to allow specific information to be released to the Clinical Care Coordinator, such as your contact information and test result. The second step is that you will be contacted to schedule an appointment.
Timeline:
If you are expecting to find out if you can be part of this clinic, the waiting period is less than two weeks from the time that you have given your consent for your results to be shared with the Clinical Care Coordinator. Once you have been contacted to schedule an appointment, the details of the clinic will be explained, including the screening tests that will be involved.
Contact Information for prospective patients:
Laura Hayes
Clinical Care Coordinator
Department of Cancer Prevention
Tel.: (514) 340-8222 extension 23910 | Fax: (514) 340-8600
Jewish General Hospital
3755 CĂ´te-Sainte-Catherine Road
Room E-740
Montreal, Quebec, Canada
H3T 1E2